Jaguar Health Inc (NASDAQ:JAGX) shares were down 7.1% on Thursday . The company traded as low as $0.13 and last traded at $0.13. Approximately 4,162,700 shares traded hands during trading, a decline of 2% from the average daily volume of 4,229,743 shares. The stock had previously closed at $0.14.
The company has a current ratio of 0.26, a quick ratio of 0.15 and a debt-to-equity ratio of 0.35. The firm has a market capitalization of $12.79, a PE ratio of -0.21 and a beta of 0.41.
About Jaguar Health
Jaguar Health, Inc, formerly Jaguar Animal Health, Inc, is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc, is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.